Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology

Biological medical products are drugs whose active components are produced only by living, genetically modified organisms or live cell cultures. Patents and exclusivity for most biopharmaceuticals has either expired or will expire soon, which enables biotechnological companies to introduce similar b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mularczyk, Aldona, Gonciarz, Maciej, Bartnik, Witold, Durlik, Marek, Eder, Piotr, Gąsiorowska, Anita, Linke, Krzysztof, Łodyga, Michał, Łykowska-Szuber, Liliana, Małecka-Panas, Ewa, Pawlik, Magdalena, Radwan, Piotr, Rydzewska, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027845/
https://www.ncbi.nlm.nih.gov/pubmed/24868291
http://dx.doi.org/10.5114/pg.2014.40842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027845/
https://www.ncbi.nlm.nih.gov/pubmed/24868291
http://dx.doi.org/10.5114/pg.2014.40842

Ejemplares similares